Dr. Jonathan A.Coleman

Top urologic surgeon specializing in adrenal cancer, prostate cancer and kidney cancer.

Book an appointment Call 646-422-4432 Get directionsClaim this page

About

Dr. Jonathan A. Coleman, MD, is a widely respected urologic oncologist specializing in the surgical treatment of prostate, kidney, adrenal, and upper urinary tract cancers. He serves as an Attending Surgeon at Memorial Sloan Kettering Cancer Center and is an Associate Professor of Urology at Weill Cornell Medical College. Dr. Coleman earned his medical degree from Cornell University Medical College and completed his residency in urology and general surgery at NewYork-Presbyterian Hospital. He later completed a fellowship in urologic oncology at the National Cancer Institute. Board-certified in Urology, Dr. Coleman brings decades of clinical expertise to the management of complex genitourinary malignancies, with a focus on innovation and patient-centered care.

Why they are a top doctor

Research papers · PubMed

266

Published, peer-reviewed work, the clearest public measure of expertise in a specialty.

Cited by other doctors

25.6k

How often other doctors and researchers build on their work.

Known for

Laparoscopic surgery, minimally invasive surgery and robotic surgery

The distinction that sets them apart from other urologic surgeons.

Background

Education

Medical school

Cornell University Medical College

Residency

General Surgery - New York Presbyterian Hospital · Urology - New York Presbyterian Hospital

Fellowships

Urologic Oncology - National Cancer Institute

Board certification

Urology

Areas of focus

Kidney (renal cell) cancer and conditions

Adrenal tumors

Prostate cancer and conditions

Laparoscopic surgery

Minimally invasive surgery

Robotic surgery

Awards

Independent research funding through a 7-year grant from the Thompson Foundation for translational research in vascular-targeted photodynamic therapy.

David H. Koch Chair, Memorial Sloan Kettering Cancer Center

Memberships and affiliations

Department of Surgery, Memorial Sloan Kettering Cancer Center

Department of Urology, Weill Cornell Medical College

American Urological Association Education and Research

Selected publications

Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients.

Epidemiology of Renal Cell Carcinoma.

Tumor Evolution and Drug Response in Patient-Derived Organoid Models of Bladder Cancer.

Single-cell sequencing links multiregional immune landscapes and tissue-resident T cells in ccRCC to tumor topology and therapy efficacy.

Molecular classification and diagnostics of upper urinary tract urothelial carcinoma.

Immunometabolic coevolution defines unique microenvironmental niches in ccRCC.

Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing.

Multicenter Phase II Clinical Trial of Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy for Patients With High-Grade Upper Tract Urothelial Carcinoma.

Primary chemoablation of low-grade upper tract urothelial carcinoma using UGN-101, a mitomycin-containing reverse thermal gel (OLYMPUS): an open-label, single-arm, phase 3 trial.

Titles as indexed on PubMed.

Where they practice

All hospitals ›

Memorial Sloan Kettering Cancer Center

New York, NY

One of the world’s oldest and largest private cancer centers, in New York City, focused only on cancer and treating every type, including rare ones.

Trials for kidney or bladder cancer

All trials ›

Examining Health Information to Improve Care for Younger Cancer Patients

Recruiting

Tests better care for people with kidney or bladder cancer. Open to kids and adults across the US.

Helping Patients with Advanced Adrenocortical Cancer Through New Treatment Combinations

Recruiting · Phase 2

Tests a new treatment for locally Advanced Adrenal Cortical Carcinoma. It checks how well it works. Open to kids and adults in 18 states.

Checking the Best Treatment After Surgery for Adrenocortical Cancer

Recruiting · Phase 3

Tests a better surgery for eNSAT Stage I Adrenal Cortex Carcinoma. It compares it with the usual care. Open to adults in 3 states.

Similar specialists

Dr. TouijerDr. Karim Touijer

SurgeonSurgeon · New York, NY · New York · NY

Recognized for expertise in both robotic and open approaches to radical prostatectomy and nephrectomy. Treats prostate cancer, bladder cancer, adrenal cancer and kidney cancer. Offers minimally invasive surgery, robotic surgery and nerve-sparing surgery. Works as an urologic surgeon. Based in New York. Chosen on merit.

Prostate cancer · Bladder cancer+2

Dr. EhdaieDr. Behfar Ehdaie

SurgeonSurgeon · New York, NY · New York · NY

Developed image-guided surgical techniques to spare nerves critical for erectile function and performs more than 250 MRI-guided prostate biopsies annually. Treats prostate cancer, bladder cancer and kidney cancer. Offers minimally invasive surgery, robotic surgery and image-guided surgery. Works as an urologic surgeon. Based in New York. Chosen on merit.

Prostate cancer · Bladder cancer+1

Dr. MatulewiczDr. Richard Matulewicz

SurgeonSurgeon · New York, NY · New York · NY

I have a particular interest in improving the way we diagnose and treat people with testicular cancer (germ cell tumors). Treats testicular cancer, bladder cancer, prostate cancer and kidney cancer. Offers open surgery, robotic surgery and retroperitoneal lymph node dissection. Works as an urologic surgeon. Based in New York. Chosen on merit.

Testicular cancer+3

About

Why they are a top doctor

Research papers · PubMed

266

Published, peer-reviewed work, the clearest public measure of expertise in a specialty.

Cited by other doctors

25.6k

How often other doctors and researchers build on their work.

Known for

Laparoscopic surgery, minimally invasive surgery and robotic surgery

The distinction that sets them apart from other urologic surgeons.

Background

Education

Medical school

Cornell University Medical College

Residency

General Surgery - New York Presbyterian Hospital · Urology - New York Presbyterian Hospital

Fellowships

Urologic Oncology - National Cancer Institute

Board certification

Urology

Areas of focus

Kidney (renal cell) cancer and conditions

Adrenal tumors

Prostate cancer and conditions

Laparoscopic surgery

Minimally invasive surgery

Robotic surgery

Awards

Independent research funding through a 7-year grant from the Thompson Foundation for translational research in vascular-targeted photodynamic therapy.

David H. Koch Chair, Memorial Sloan Kettering Cancer Center

Memberships and affiliations

Department of Surgery, Memorial Sloan Kettering Cancer Center

Department of Urology, Weill Cornell Medical College

American Urological Association Education and Research

Selected publications

Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients.

Epidemiology of Renal Cell Carcinoma.

Tumor Evolution and Drug Response in Patient-Derived Organoid Models of Bladder Cancer.

Single-cell sequencing links multiregional immune landscapes and tissue-resident T cells in ccRCC to tumor topology and therapy efficacy.

Molecular classification and diagnostics of upper urinary tract urothelial carcinoma.

Immunometabolic coevolution defines unique microenvironmental niches in ccRCC.

Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing.

Multicenter Phase II Clinical Trial of Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy for Patients With High-Grade Upper Tract Urothelial Carcinoma.

Primary chemoablation of low-grade upper tract urothelial carcinoma using UGN-101, a mitomycin-containing reverse thermal gel (OLYMPUS): an open-label, single-arm, phase 3 trial.

Titles as indexed on PubMed.

Similar specialists